Prevalence of Anti-HCV antibody in haemodialysis patients referring to haemodialysis centers in Jahrom
Authors
Abstract
Introduction: Hepatitis C virus (HCV) is a major cause of chronic liver disease among chronic renal failure (CRF) patients undergoing maintenance hemodialysis.The Management of HCV-related liver disease is a major health concern in patients with end-stage renal disease (ESRD) undergoing haemodialysis. To investigate the prevalence of HCV infection in patients on haemodialysis in Jahrom.
Material and Methods: This cross-sectional study was conducted on all haemodialysis patients in Jahrom in April- May 2006. All the patients were screened for anti-HCV antibodies, using ELISA and confirmed by RIBA methods.
Results: The findings of this study revealed that 3 patients(8.8%) were anti-HCV positive as confirmed by Elisa method and z (5.9%)as confirmed by Riba method.
Conclusion: The seroprevalence of HCV among the haemodialysis patients of Jahrom was 5.9% ,being is lower than that of haemodialysis patients in other countries.
Keywords
1. Paraskijevic B, Vasic-Jovanovic V. Frequency of anti-HCV antibodies in haemodialysis patients. Journal of Regional Section of Serbian Medical Association in Zajecar. (2003); 28(1-2): 5-8.
2. Young KKY, Resnick RM, Myers TW. Detection of Hepatitis C virus RNA by combined reverse transcription-polymerase chain reaction assay. J Medical Microbiology. (1993); 31: 882-886.
3. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitranfused thalassemic children in shiraz, IRAN. J Pediatr Child Health. (2001); 37: 564-6.
4. Abid Hossain Mollah, Nazmum Nahar, Md. A. Siddique, Kazi Selim Anwar, Tariq Hassan, Md. Golam Azam. Common transfusion-transmitted infectious agents among thalassemic children in Bangladesh. J Health Poul Nutr. (2003). Mar; 21(1): 67-71.
5. Kebudi R, Ayan I, Yilmaz G, Akici F, Gorgun O, Badur S. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Med Peddiatr Oncol. (2000); 34: 102-5.
6. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Al Jama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol. (2000); 54: 151-156.
7. Amarapurkar DN, Kumar A, Vaidya S, Muri P, Bichile SK, Karlo RH, et al. Frequency of hepatitis B, hepatitis C and human immunodeficiency virus infections in multiply transfused thalassemics. Indian J Gasteroentrol. (1992); 11: 80-81.
8. Agarwal MB, Malkan GH, Bhave AA, Vishwanathan C, Billa V, Dube SR, et al. Antibodies to hepatitis C virus in multiply transfused thalassemics - Indian experience. J Assoc Physicians India. (1993); 41: 195-7.
9. Abdulkarim AS, Zein NN, Germer JJ et al. Hepatitis C virus genotypes and Hepatitis G virus in haemodialysis patients in Syria: identification of two novel Hepatitis C virus subtypes. Am J Trop Med Hyg. (1999); 59: 571-576.
10. Othman B, Monem F. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus, Syria. Infection. 2001 Oct; 29(5):262-5.
11. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis. 2001 Nov; 38(5):1009-15.
12. Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Faranna P, Pagano A, Locatelli F. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant. 1997 Jul; 12(7):1394-8.
13. Jamal R, Fadzillah G, Zulkifli SZ, Yasmin M. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: resulta from a thalassemia day care center in Malaysia. Southeast Asian J Trop Med Public Health. (1998). Dec; 29(4): 792-794.
14. Taziki O, Espahbodi F. Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients. Saudi J Kidney Dis Transpl 2008;19:475-8.
15. Mahnaz Taremi, Manouchehr Khoshbaten, Latif Gachkar, Mohammad Javad EhsaniArdakani, and MohammadReza Zali. Hepatitis E virus infection in hemodialysis patients: A seroepidemiological survey in Iran. BMC Infect Dis. 2005; 5: 36. 2334-6.
16. Fissel RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int. 2004; 65: 2335–2342.
17. Petrosillo N, Gilli P, Serraino D, Dentico P, Mele A, Ragni P, Puro V, Casalino C, Ippolito G. Prevalence of infected patients and understaffing have a role in hepatitis C vírus transmission in dialysis. Am J Kidney dis. 2001; 37: 1004–1010.
18. Saxena AK, Panhotra BR, Naguib M, Aboras MN, Sundaram DS, Venkateshappa CK, Khan WU. Prevalence of hepatitis C antibodies among hemodialysis patients in Al-hasa region of saudi arabia. Saudi J Kidney Dis Transpl. 2001 Oct-Dec;12(4):562-5.
19. Iwasa Y, Otsubo S, Sugi O, Sato K, Asamiya Y, Eguchi A, Iwasaki T, Matsuda N, Kikuchi K, Ikebe N, Miwa N, Kimata N, Uchida K, Uchida S, Nitta K, Akiba T. Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clin Exp Nephrol. 2008 Feb;12(1):53-7.
20. Carneiro MAS, Martins RMB, Teles AS, Silva AS, Lopes Carmen L, Cardoso DDP, Vanderborght BO, Yoshida CF. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz. 2001; 96: 765–769.
21. Santana GO, Cotrim HP, Mota E, Paraná R, Santana NP, Lyra L. Anticorpo contra o vírus C da hepatite em pacientes sob programa de hemodiálise em Salvador, BA, Brasil. Arq Gastroenterol. 2001; 38: 24–31.
22. Souza KP, Luz JA, Teles SA, Carneiro MAS, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Mem Inst Oswaldo Cruz. 2003; 98: 599–603.
23. Busek SU, Baba EH, Tavares Filho HA, Pimenta L, Salomão A, Correa-Oliveira R, Oliveira GC. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 2002; 97: 775–778.
24. Moreira R, Pinho JRR, Fares J, Oba IT, Cardoso MR, Saraceni P, Granato C. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies. Can J Microbiol. 2003; 49: 503–507.
25. Sekkat S, Kamal N, Benali B, Fellah H, Amazian K, Bourquia A, El Kholti A, Benslimane A. Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. Nephrol Ther. 2008 Apr;4(2):105-110.
26- امام قریشی فاطمه، فتحی غلام عباس، محتشمی علی. بررسی دموگرافی و شیوع هپاتیت B و C و HIV در اهداکنندگان خون شهرستان جهرم سال های 1382-1380 . فصلنامه علمی-پژوهشی خون. دوره 3. شماره 7- زمستان 1384- 378-373.